The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Nicastrin, Presenilin, APH-1, and PEN-2 Form Active γ-Secretase Complexes in Mitochondria
Open accessAbstract
Mitochondria are central in the regulation of cell death. Apart from providing the cell with ATP, mitochondria also harbor several death factors that are released upon apoptotic stimuli. Alterations in mitochondrial functions, increased oxidative stress, and neurons dying by apoptosis have been detected in Alzheimer's disease patients. These findings suggest that mitochondria may trigger the abnormal onset of neuronal cell death in Alzheimer's disease. We previously reported that presenilin 1 (PS1), which is often mutated in familial forms of Alzheimer's disease, is located in mitochondria and hypothesized that presenilin mutations may sensitize cells to apoptotic stimuli at the mitochondrial level. Presenilin forms an active gamma-secretase complex together with Nicastrin (NCT), APH-1, and PEN-2, which among other substrates cleaves the beta-amyloid precursor protein (beta-APP) generating the amyloid beta-peptide and the beta-APP intracellular domain. Here we have identified dual targeting sequences (for endoplasmic reticulum and mitochondria) in NCT and showed expression of NCT in mitochondria by immunoelectron microscopy. We also showed that NCT together with APH-1, PEN-2, and PS1 form a high molecular weight complex located in mitochondria. gamma-secretase activity in isolated mitochondria was demonstrated using C83 (alpha-secretase-cleaved C-terminal 83-residue beta-APP fragment from BD8 cells lacking presenilin and thus gamma-secretase activity) or recombinant C100-Flag (C-terminal 100-residue beta-APP fragment) as substrates. Both systems generated an APP intracellular domain, and the activity was inhibited by the gamma-secretase inhibitors l-685,458 or Compound E. This novel localization of NCT, PS1, APH-1, and PEN-2 expands the role and importance of gamma-secretase activity to mitochondria.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“accumulating data certainly do suggest APP and Aβ, as well as the entire γ-secretase complex, physically associate with mitochondria and can effect changes in mitochondrial function [58-67].”
From The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives (2014) · cites this paper as [65]
Citations
Cites
THE MITOCHONDRIAL DEATH/LIFE REGULATOR IN APOPTOSIS AND NECROSIS
Kroemer, G., Dallaporta, B., & Resche-Rigon, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.619 · Cited by 1,975
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303
Newmeyer, D. D., & Ferguson-Miller, S. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00116-8 · Cited by 1,272
Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing
Yu, G., Nishimura, M., Arawaka, S., Levitan, D. J., Zhang, L., Tandon, A., Song, Y., Rogaeva, E. A., Chen, F., Kawarai, T., et al. (2000) · Nature · doi:10.1038/35024009 · Cited by 929
Reconstitution of γ-secretase activity
Edbauer, D., Winkler, E., Regula, J. T., Pesold, B., Steiner, H., & Haass, C. (2003) · Nature Cell Biology · doi:10.1038/ncb960 · Cited by 914
Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
Li, Y.-M., Xu, M., Lai, M.-T., Huang, Q., Castro, J. L., DiMuzio-Mower, J., Harrison, T., Lellis, C., Nadin, A., Neduvelil, J. G., et al. (2000) · Nature · doi:10.1038/35015085 · Cited by 866
γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2
Kimberly, W. T., LaVoie, M. J., Ostaszewski, B. L., Ye, W., Wolfe, M. S., & Selkoe, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1037392100 · Cited by 763
Anandatheerthavarada, H. K., Biswas, G., Robin, M.-A., & Avadhani, N. G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207030 · Cited by 571
Brain cytochrome oxidase in Alzheimer's disease
Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L., Wilson, J. M., DiStefano, L. M., & Nobrega, J. N. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09439.x · Cited by 537
Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state
Li, Y., Lai, M., Xu, M., Huang, Q., DiMuzio‐Mower, J., Sardana, M. K., Shi, X., Yin, K., Shafer, J. A., & Gardell, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110126897 · Cited by 523
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 256
Ntsapi, C., & Loos, B. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.07.014 · Cited by 65
Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer’s Disease
Eysert, F., Kinoshita, P. F., Mary, A., Vaillant-Beuchot, L., Checler, F., & Chami, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249521 · Cited by 63
Fiala, J. C., Feinberg, M. D., Peters, A., & Barbas, H. (2007) · Brain Structure and Function · doi:10.1007/s00429-007-0153-1 · Cited by 64
Rethinking Alzheimer's Disease Therapy: Are Mitochondria the Key?
Ankarcrona, M., Mangialasche, F., & Winblad, B. G. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100327 · Cited by 60
Mutations that affect mitochondrial functions and their association with neurodegenerative diseases
Dhillon, V. S., & Fenech, M. F. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2013.09.001 · Cited by 61
Superoxide Anion, Uncoupling Proteins and Alzheimer’s Disease
Wu, Z., Zhao, Y., & Zhao, B. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.09-104-2 · Cited by 60
Synaptic and Endosomal Localization of Active γ-Secretase in Rat Brain
Frykman, S., Hur, J.-Y., Frånberg, J., Aoki, M., Winblad, B., Nahalkova, J., Behbahani, H., & Tjernberg, L. O. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008948 · Cited by 57
Mitochondrial Cascade Hypothesis of Alzheimer's Disease: Myth or Reality?
Mancuso, M., Coppedè, F., Murri, L., & Siciliano, G. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1761 · Cited by 56
Mitochondria, cholesterol and amyloid β peptide: a dangerous trio in Alzheimer disease
Colell, A., Fernández, A., & Fernández-Checa, J. C. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9242-6 · Cited by 53
The biological foundation of the genetic association of TOMM40 with late-onset Alzheimer's disease
Zeitlow, K., Charlambous, L., Ng, I., Gagrani, S., Mihovilovic, M., Luo, S., Rock, D. L., Saunders, A. M., Roses, A. D., & Gottschalk, W. K. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.031 · Cited by 56
Mitochondria in Aging and Alzheimer's Disease
Crouch, P. J., Cimdins, K., Duce, J. A., Bush, A. I., & Trounce, I. A. (2007) · Rejuvenation Research · doi:10.1089/rej.2007.0592 · Cited by 54
Presenilin1 Regulates Histamine Neuron Development and Behavior in Zebrafish, Danio rerio
Sundvik, M., Chen, Y., & Panula, P. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1802-12.2013 · Cited by 55
Penna, C. R. R., Perrelli, M. G., Tullio, F., Angotti, C., Camporeale, A., Poli, V., & Pagliaro, P. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0371-z · Cited by 51
Identification of Novel γ-Secretase-associated Proteins in Detergent-resistant Membranes from Brain
Hur, J., Teranishi, Y., Kihara, T., Yamamoto, N. G., Inoue, M., Hosia, W., Hashimoto, M., Winblad, B. G., Frykman, S., & Tjernberg, L. O. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.246074 · Cited by 51
Winslow, A. R., Moussaud, S., Zhu, L., Post, K. L., Dickson, D. W., Berezovska, O., & McLean, P. J. (2014) · Brain · doi:10.1093/brain/awu119 · Cited by 48
Characterizing the structural ensemble of γ-secretase using a multiscale molecular dynamics approach
Aguayo‐Ortiz, R., Chávez-García, C., Straub, J. E., & Domı́nguez, L. (2017) · Chemical Science · doi:10.1039/c7sc00980a · Cited by 48
HIG1, a novel regulator of mitochondrial γ‐secretase, maintains normal mitochondrial function
Hayashi, H., Nakagami, H., Takeichi, M., Shimamura, M., Koibuchi, N., Oiki, E., Sato, N., Koriyama, H., Mori, M., Araujo, R. G., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-196063 · Cited by 46
β-Amyloid Peptide: the Cell Compartment Multi-faceted Interaction in Alzheimer’s Disease
Picone, P., Nuzzo, D., Giacomazza, D., & Carlo, M. D. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00116-9 · Cited by 47
Serviddio, G., Romano, A. D., Cassano, T., Bellanti, F., Altomare, E., & Vendemiale, G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796904740 · Cited by 45
Crouch, P. J., Barnham, K. J., Duce, J. A., Blake, R. E., Masters, C. L., & Trounce, I. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04050.x · Cited by 46
Coon, K. D., Valla, J., Szelinger, S., Schneider, L. E., Niedzielko, T. L., Brown, K. M., Pearson, J. V., Halperin, R. F., Dunckley, T. L., Papassotiropoulos, A., et al. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.07.002 · Cited by 47
Strategic Role for Mitochondria in Alzheimer's Disease and Cancer
Hedskog, L., Zhang, S., & Ankarcrona, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4259 · Cited by 45
Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes
Moreira, P. I., Cardoso, S. M., Pereira, C., Santos, M. S., & Oliveira, C. R. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824651 · Cited by 44
Architecture, function and prediction of long signal peptides
Hiss, J. A., & Schneider, G. (2009) · Briefings in Bioinformatics · doi:10.1093/bib/bbp030 · Cited by 43
Behbahani, H., Shabalina, I. G., Wiehager, B., Concha, H., Hultenby, K. R., Petrovič, N., Nedergaard, J., Winblad, B. G., Cowburn, R. F., & Ankarcrona, M. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20990 · Cited by 42
Spina, E., Ferrari, R. R., Pellegrini, E., Colombo, M. M., Poloni, T. E., Guaita, A., & Davin, A. (2025) · Cells · doi:10.3390/cells14030229 · Cited by 45
Mitochondrial Cholesterol in Alzheimer's Disease and Niemann–Pick Type C Disease
Torres, S., García‐Ruiz, C., & Fernández-Checa, J. C. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01168 · Cited by 42
Ca2+ dysfunction in neurodegenerative disorders: Alzheimer's disease
Fedrizzi, L., & Carafoli, E. (2011) · BioFactors · doi:10.1002/biof.157 · Cited by 40
Marks, N., & Berg, M. J. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0054-1 · Cited by 38
Zhang, X., Wang, L., Li, B., Shi, J., Xu, J. F., & Yuan, M. (2023) · Pharmaceuticals · doi:10.3390/ph16020277 · Cited by 42
Interactions between amyloid, amyloid precursor protein, and mitochondria
Wilkins, H. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220518 · Cited by 37
γ-Secretase Is a Functional Component of Phagosomes
Jutras, I., Laplante, A., Boulais, J., Brunet, S., Thinakaran, G., & Desjardins, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504069200 · Cited by 39
When, where and how? Focus on neuronal calcium dysfunctions in Alzheimer’s Disease
Agostini, M., & Fasolato, C. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.06.008 · Cited by 40
Association of Omi/HtrA2 with γ-secretase in mitochondria
Behbahani, H., Pavlov, P. F., Wiehager, B., Nishimura, T., Winblad, B. G., & Ankarcrona, M. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.08.004 · Cited by 37
Wu, Z., Zhu, Y., Cao, X., Sun, S., & Zhao, B. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8675-z · Cited by 36
Mitochondrial dysfunction induced by disease relevant AβPP and tau protein mutations
Keil, U., Hauptmann, S., Bonert, A., Scherping, I., Eckert, A., & Müller, W. E. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9206 · Cited by 36
Lamarca, V., Sanz-Clemente, A., Pérez‐Pé, R., Martínez‐Lorenzo, M. J., Halaihel, N., Muniesa, P., & Carrodeguas, J. A. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00431.2006 · Cited by 34
Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2018) · BioMed Research International · doi:10.1155/2018/1483791 · Cited by 36
Amyloid precursor protein and mitochondria
Strope, T. A., & Wilkins, H. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102651 · Cited by 37
The Mitochondrial Secret(ase) of Alzheimer's Disease
Young, K. J., & Bennett, J. P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100360 · Cited by 34
Characterization of Mitochondrial Dysfunction in the 7PA2 Cell Model of Alzheimer's Disease
Jakovljevic, N. K., Magnifico, M. C., Arese, M., Meli, G., Forte, E., Lecci, A., Manca, A., Giuffrè, A., Mastronicola, D., Sarti, P., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130728 · Cited by 32
Effect of Gender on Mitochondrial Toxicity of Alzheimer's A β Peptide
Viña, J., Lloret, A., Vallés, S. L., Borrás, C., Badía, M.-C., Pallardó, F. V., Sastre, J., & Alonso, M.-D. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1773 · Cited by 33
Oxidative Stress and Alzheimer’s Disease
Singh, S. K., Castellani, R. J., & Perry, G. L. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_10 · Cited by 33
A Functional Role for ADAM10 in Human Immunodeficiency Virus Type-1 Replication
Friedrich, B. M., Murray, J. L., Li, G., Sheng, J., Hodge, T. W., Rubin, D. H., O’Brien, W. A., & Ferguson, M. R. (2011) · Retrovirology · doi:10.1186/1742-4690-8-32 · Cited by 31
Pająk, B., Kania, E., & Orzechowski, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1805304 · Cited by 31
Corrêa-Velloso, J. C., Gonçalves, M. C., Naaldijk, Y., Oliveira‐Giacomelli, Á., Pillat, M. M., & Ulrich, H. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.033 · Cited by 31
Suga, K., Saito, A., Tomiyama, T., Mori, H., & Akagawa, K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03210.x · Cited by 30
Dementia, stroke and migraine — Some common pathological mechanisms
Sas, K., Párdutz, Á., Toldi, J., & Vécsei, L. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.001 · Cited by 30
Neurosecretases provide strategies to treat sporadic and familial Alzheimer disorders
Marks, N., & Berg, M. J. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.020 · Cited by 30
Alexiou, A. T., Soursou, G., Chatzichronis, S., Gasparatos, E., Kamal, M. A., Yarla, N. S., Perveen, A., Barreto, G. E., & Ashraf, G. M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1397-x · Cited by 28
Anandatheerthavarada, H. K., & Devi, L. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.5.343 · Cited by 28
Mitochondrial dysfunction and Alzheimer's disease: New developments
Mancuso, M., Siciliano, G., Filosto, M., & Murri, L. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9203 · Cited by 28
Presenilin-mediated signal transduction
Cowburn, R. F., Popescu, B. O., Ankarcrona, M., Dehvari, N., & Cedazo-Mı́nguez, Á. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.05.053 · Cited by 27
Pathogenic role of mitochondrial amyloid-β peptide
Chen, J. X., & Yan, S. D. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1517 · Cited by 26
Frykman, S., Teranishi, Y., Hur, J., Matton, A., Yamamoto, N. G., Ankarcrona, M., Nishimura, T., Winblad, B. G., Bogdanović, N., Schedin‐Weiss, S., et al. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.03.016 · Cited by 27
Hiss, J. A., Resch, E., Schreiner, A., Meißner, M., Starzinski‐Powitz, A., & Schneider, G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002767 · Cited by 24
Walser, M., Hansén, A., Svensson, P., Jernås, M., Oscarsson, J., Isgaard, J., & Åberg, N. D. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2010.11.002 · Cited by 22
Volloch, V., Olsen, B. R., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.02-1007 · Cited by 23
Mamada, N., Tanokashira, D., Ishii, K., Tamaoka, A., & Araki, W. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.035 · Cited by 22
Widespread γ-secretase activity in the cell, but do we need it at the mitochondria?
Teng, F. Y. H., & Tang, B. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.131 · Cited by 21
Hassan, R., Rabea, A. A., Ragae, A., & Sabry, D. (2019) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2019.104596 · Cited by 22
Regulation of distinct pools of amyloid β-protein by multiple cellular proteases
Leissring, M. A., & Turner, A. J. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt194 · Cited by 20
p120-Catenin Is a Key Component of the Cadherin–γ-Secretase Supercomplex
Kiss, A., Troyanovsky, R. B., & Troyanovsky, S. M. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-04-0394 · Cited by 19
Minogue, A. M., Stubbs, A. K., Frigerio, C. S., Boland, B., Fadeeva, J. V., Tang, J., Selkoe, D. J., & Walsh, D. M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.008 · Cited by 20
Monoamine Oxidase-A Physically Interacts with Presenilin-1(M146V) in the Mouse Cortex
Wei, Z.-L., Gabriel, G. G., Rui, L., Cao, X., Pennington, P. R., Chlan‐Fourney, J., Nazarali, A., Baker, G., & Mousseau, D. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111241 · Cited by 18
Mitochondrial amyloid-beta peptide: Pathogenesis or late-phase development?
Yan, S. D., Xiong, W., & Stern, D. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9205 · Cited by 18
Experimental approaches for altering the expression of Abeta‐degrading enzymes
Loeffler, D. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15762 · Cited by 18
Role of Mitochondrial Protein Import in Age-Related Neurodegenerative and Cardiovascular Diseases
Bogorodskiy, A. O., Okhrimenko, I. S., Burkatovskii, D., Jakobs, P., Maslov, I., Gordeliy, V., Dencher, N. A., Gensch, T., Voos, W., Altschmied, J., et al. (2021) · Cells · doi:10.3390/cells10123528 · Cited by 19
Activated Caspase-3 and Neurodegeneration and Synaptic Plasticity in Alzheimer’s Disease
Płóciennik, A., Prendecki, M., Zuba, E. B., Siudzinski, M., & Dorszewska, J. (2015) · Advances in Alzheimer s Disease · doi:10.4236/aad.2015.43007 · Cited by 17
γ-Secretase-regulated Proteolysis of the Notch Receptor by Mitochondrial Intermediate Peptidase
Lee, S.-F., Srinivasan, B., Sephton, C. F., Dries, D. R., Wang, B., Yu, C., Wang, Y., Dewey, C. M., Shah, S., Jiang, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.243154 · Cited by 19
Kalra, J. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.343884 · Cited by 16
HtrA2 interacts with A beta peptide but does not directly alter its production or degradation.
Liu, M.-L., Liu, M.-J., Kim, J., Kim, H., Kim, J.-H., & Hong, S. (2005) · PubMed · Cited by 16
Pennington, P. R., Wei, Z.-L., Rui, L., Doig, J., Graham, B., Kuski, K., Gabriel, G. G., & Mousseau, D. (2011) · Journal of neural transmission · doi:10.1007/s00702-011-0616-7 · Cited by 15
Wang, P., Guan, P., Guo, J., Cao, L., Xu, G., Yu, X., Wang, Y., & Wang, Z. (2016) · Aging Cell · doi:10.1111/acel.12495 · Cited by 15
From Small Peptides to Large Proteins against Alzheimer’sDisease
Picone, P., Sanfilippo, T., Vasto, S., Baldassano, S., Guggino, R., Nuzzo, D., Bulone, D., Biagio, P. L. S., Muscolino, E., Monastero, R., et al. (2022) · Biomolecules · doi:10.3390/biom12101344 · Cited by 16
Amyloid protein aggregates: new clients for mitochondrial energy production in the brain?
Sivanesan, S., Chang, E., Howell, M. D., & Rajadas, J. (2020) · FEBS Journal · doi:10.1111/febs.15225 · Cited by 16
Lechuga, G. C., Napoleão-Pêgo, P., Bottino, C. C. G., Pinho, R. T., Provance, D. W., & De-Simone, S. G. (2020) · Biomolecules · doi:10.3390/biom10111564 · Cited by 13
Amyloid precursor protein and Presenilin 1 interaction studied by FRET in human H4 cells.
NIZZARI, M., VENEZIA, V., BIANCHINI, P., CAORSI, V., DIASPRO, A., REPETTO, E., THELLUNG, S., CORSARO, A., CARLO, P., SCHETTINI, G., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.091 · Cited by 10
Dematteis, G., Gong, C., Malecka, J., Tonelli, E., Genazzani, A. A., Tapella, L., Eleuteri, A. M., Lim, D., & Bonfili, L. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01793-9 · Cited by 14
Altering Mitochondrial Dysfunction as an Approach to Treating Alzheimer’s Disease
Colca, J. R., & Feinstein, D. L. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00005-2 · Cited by 14
A Protective Role of Translocator Protein in Alzheimer’s Disease Brain
Jung, M. E. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200217105950 · Cited by 17
Ratnayaka, J. A., Paraoan, L., Spiller, D. G., Hiscott, P. S., Nelson, G., White, M., & Grierson, I. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.01.030 · Cited by 14
Miyoshi, K., Ohyagi, Y., Sakae, N., Motomura, K., Ma, L., Taniwaki, T., Furuya, H., Tabira, T., & Kira, J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0989 · Cited by 13
The reciprocal relationship between amyloid precursor protein and mitochondrial function
Strope, T. A., & Wilkins, H. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16183 · Cited by 15
Chronic benzodiazepine suppresses translocator protein and elevates amyloid β in mice
Tan, S., Metzger, D. B., & Jung, M. E. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.07.005 · Cited by 14
BACE1 Inhibition Increases Susceptibility to Oxidative Stress by Promoting Mitochondrial Damage
Francelin, C., Mitter, S. K., Qian, Q., Barodia, S. K., Ip, C. S., Qi, X., Gu, H., Quigley, J., Goldberg, M. S., Grant, M. B., et al. (2021) · Antioxidants · doi:10.3390/antiox10101539 · Cited by 13
HtrA2 Interacts with Aβ Peptide but Does Not Directly Alter Its Production or Degradation
Liu, M.-L., Liu, M., Kim, J., Kim, H., Kim, J.-H., & Hong, S. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13202-x · Cited by 18
Gao, Q.-C., Liu, G.-L., Wang, Q., Zhang, S., Ji, Z., Wang, Z., Wu, M., Yu, Q., & He, P. F. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103420 · Cited by 11
Du, F., Yu, Q., Yan, S., Zhang, Z., Vangavaragu, J. R., Chen, D., Yan, S. S., & Yan, S. S. (2021) · Aging Cell · doi:10.1111/acel.13368 · Cited by 11
Alzheimer’s Disease Prevention and Treatment: Case for Optimism
Volloch, V., Olsen, B. R., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.02-1008 · Cited by 11
Zhao, F., Qiao, P., Yan, N., Gao, D., Liu, M., & Yan, Y. P. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1807-7 · Cited by 11
A lzheimer's Disease Biomarkers: More Than Molecular Diagnostics
Anderson, D. C. (2013) · Drug Development Research · doi:10.1002/ddr.21073 · Cited by 9
Genetic ablation of neuronal mitochondrial calcium uptake impedes Alzheimer’s disease progression
Jadiya, P., Berezhnaya, E. V., Kolmetzky, D. W., Tomar, D., Cohen, H. M., Shukla, S., Thomas, M., Khaledi, S., Garbincius, J. F., Kennedy, L., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00809-w · Cited by 11
FLZ inhibited γ-secretase selectively and decreased Aβ mitochondrial production in APP-SH-SY5Y cells
Ye, X., Tai, W., Bao, X., Chen, X., & Zhang, D. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0918-4 · Cited by 10
Wang, K., & Zhang, W. (2021) · Synapse · doi:10.1002/syn.22196 · Cited by 11
Stavros, J. (2013) · InTech eBooks · doi:10.5772/56079 · Cited by 9
Volloch, V., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.02-1009 · Cited by 10
Advances in our Understanding of Neurodegeneration
Jellinger, K. A. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50142-3 · Cited by 9
Resch, E., Quaiser, S., Quaiser, T., Schneider, G., Starzinski‐Powitz, A., & Schreiner, A. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00765.x · Cited by 9
The Genetic Basis of Alzheimer's Disease
Hooli, B. V., & Tanzi, R. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00034-2 · Cited by 9
Metadata
- Authors
- Hansson, C. A., Frykman, S., Farmery, M. R., Tjernberg, L. O., Nilsberth, C., Pursglove, S. E., Ito, A., Winblad, B., Cowburn, R. F., Thyberg, J., & Ankarcrona, M.
- Affiliations
- Karolinska Institutet (SE)
- The University of Sydney (AU)
- Corresponding author
- Ankarcrona, Maria
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 279
- Issue
- 49
- Pages
- 51654-51660
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2132814291
- Cited by
- 256
- References
- 41
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 8 · 2020: 5 · 2019: 9 · 2018: 8 · 2017: 7 · 2016: 12 · 2015: 7 · 2014: 10 · 2013: 12 · 2012: 22
- FWCI
- 12.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- gamma-secretase, mitochondria, nicastrin, presenilin 1, APH-1, Pen-2, Alzheimer's disease, amyloid precursor protein, APP intracellular domain, mitochondrial targeting sequence, neuronal apoptosis, gamma-secretase inhibitors, compound E
- MeSH terms
- Adenosine Triphosphate, Alzheimer Disease, Amino Acid Sequence, Animals, Brain, Cholic Acids, Detergents, Electrophoresis, Polyacrylamide Gel, Endoplasmic Reticulum, Golgi Apparatus, Male, Membrane Glycoproteins, Membrane Proteins, Mitochondria, Molecular Sequence Data, Neurons, Peptide Hydrolases, Endopeptidases, Peptides, Subcellular Fractions, Immunoblotting, Signal Transduction, Amyloid beta-Peptides, Microscopy, Immunoelectron, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Rats, Sprague-Dawley, Apoptosis, Protein Structure, Tertiary, Oxidative Stress, Immunoprecipitation, Rats, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review